The 72nd Annual Workers' Compensation Educational Conference and 29th Annual Safety & Health Conference (WCI 360) The WCI360 Conference focuses on national workers’ compensation and occupational safety and health industries. During the 72nd Conference, speakers will present on issues of common concern to all Workers’ Comp professionals, regardless of jurisdiction or state, issues that have no geographical boundaries. Mitchell’s is pleased to participate as an exhibitor at the Conference with information on our Workers’ Compensation and Pharmacy Solutions. Our team will be onsite for booth demos, 1x1 meetings and a small meet and greet for our Pharmacy Solutions team. Please contact your Mitchell representative for more detail.
More stories
10 Work From Home Tips During COVID-19 for Insurance Professionals
Working from home during the COVID-19 pandemic? Here are 10 tips to help insurance professionals as they transition and adjust to working from home.
Tips from Coventry Employees for Working from Home
In March, many people found themselves suddenly thrust into the weird and wonderful world of working from home (WFH). We thought we’d take a break from our usual format of offering workers’ comp industry trends and insights to share some tips on working from home.
How COVID-19 is Impacting Prior Auth Rules in Comp
The COVID-19 pandemic has dramatically changed the health and social landscape of our country, impacting injured workers and their treating providers from several vectors.
CARES Act: Impact on Repair Industry According to ASA
The Automotive Service Association hosted a webinar on how to effectively handle the trickle-down effect of the COVID-19 outbreak as a small business owner.
Payment for Vehicle Disinfection During Crisis
Insurance companies adapt with new policies to account for time spent disinfecting vehicles during the coronavirus outbreak.
Montana Requests Implementation Delay of Drug Formulary for Legacy Claims
The Montana Department of Labor and Industry is asking insurers and employers to delay the application of the drug formulary for legacy claims until after the COVID-19 crisis has passed.